TD Cowen lowered the firm’s price target on Clorox (CLX) to $117 from $120 and keeps a Hold rating on the shares. The firm lowered its estimates to more fully account for operating deleverage stemming from the company’s 1Q service disruptions during its ERP transition and lingering weakness in organic sales growth in the firm’s retail tracking data.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $112 from $118 at Barclays
- Clorox’s Financial Challenges and Operational Disruptions Lead to Hold Rating
- Clorox price target raised to $135 from $133 at JPMorgan
- Clorox Faces Challenges with ERP Implementation and Competitive Pressures, Leading to Hold Rating
- Clorox Faces Operational Challenges and Market Share Concerns Amid ERP Transition, Earning a Hold Rating